Analysis Of Income And Expense [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183198

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Analysis of income and expense [abstract]
Revenue [abstract]
Revenue
22,668,000 EUR
9,030,000 EUR
Material income and expense [abstract]
Research and development expense
85,243,000 EUR
78,458,000 EUR
Selling, general and administrative expense [abstract]
Selling expense
1,871,000 EUR
1,434,000 EUR
General and administrative expense
12,515,000 EUR
15,933,000 EUR
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations
66,000 EUR
66,000 EUR
Other comprehensive income, before tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations
- EUR
66,000 EUR
Income tax relating to components of other comprehensive income [abstract]
Income tax relating to components of other comprehensive income that will be reclassified to profit or loss
3,597,000 EUR
2,576,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
17,300,000 EUR
- EUR
- EUR
134,175,000 EUR
116,875,000 EUR
92,086,000 EUR
- EUR
89,086,000 EUR
- EUR
3,000,000 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
134,175,000 EUR
89,086,000 EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests
- EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.